Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations

Ariel Beresniak; Jürgen Braun; Paolo Cortesi; Gianfranco Ferraccioli; Merete Lund Hetland; Johannes W.G. Jacobs; Arthur Kavanaugh; Raashid Luqmani; Marta Mosca; Theodore Pincus; Duncan Porter; Vappu Rantalaiho; Angelo Ravelli; David L. Scott; Josef Smolen; Christian Thielscher; Giuseppe Turchetti; Marianne Van Den Broek; Yusuf Yazici

Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations

Ariel Beresniak^*, Jürgen Braun, Paolo Cortesi, Gianfranco Ferraccioli, Merete Lund Hetland, Johannes W.G. Jacobs, Arthur Kavanaugh, Raashid Luqmani, Marta Mosca, Theodore Pincus, Duncan Porter, Vappu Rantalaiho, Angelo Ravelli, David L. Scott, Josef Smolen, Christian Thielscher, Giuseppe Turchetti, Marianne Van Den Broek, Yusuf Yazici

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Journal	Clinical and Experimental Rheumatology
Volume	30
Issue number	4 SUPPL.73
Publication status	Published - 4 Dec 2012

Cite this

Beresniak, A., Braun, J., Cortesi, P., Ferraccioli, G., Hetland, M. L., Jacobs, J. W. G., Kavanaugh, A., Luqmani, R., Mosca, M., Pincus, T., Porter, D., Rantalaiho, V., Ravelli, A., Scott, D. L., Smolen, J., Thielscher, C., Turchetti, G., Van Den Broek, M., & Yazici, Y. (2012). Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations. Clinical and Experimental Rheumatology, 30(4 SUPPL.73).

@article{5311eea06edd4595aee7ad3d67aecbec,

title = "Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations",

author = "Ariel Beresniak and J{\"u}rgen Braun and Paolo Cortesi and Gianfranco Ferraccioli and Hetland, {Merete Lund} and Jacobs, {Johannes W.G.} and Arthur Kavanaugh and Raashid Luqmani and Marta Mosca and Theodore Pincus and Duncan Porter and Vappu Rantalaiho and Angelo Ravelli and Scott, {David L.} and Josef Smolen and Christian Thielscher and Giuseppe Turchetti and {Van Den Broek}, Marianne and Yusuf Yazici",

year = "2012",

month = dec,

day = "4",

language = "English",

volume = "30",

journal = "Clinical and Experimental Rheumatology",

issn = "0392-856X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "4 SUPPL.73",

}

Beresniak, A, Braun, J, Cortesi, P, Ferraccioli, G, Hetland, ML, Jacobs, JWG, Kavanaugh, A, Luqmani, R, Mosca, M, Pincus, T, Porter, D, Rantalaiho, V, Ravelli, A, Scott, DL, Smolen, J, Thielscher, C, Turchetti, G, Van Den Broek, M & Yazici, Y 2012, 'Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations', Clinical and Experimental Rheumatology, vol. 30, no. 4 SUPPL.73.

TY - JOUR

T1 - Treat-to-target in rheumatoid arthritis

T2 - Clinical and pharmacoeconomic considerations

AU - Beresniak, Ariel

AU - Braun, Jürgen

AU - Cortesi, Paolo

AU - Ferraccioli, Gianfranco

AU - Hetland, Merete Lund

AU - Jacobs, Johannes W.G.

AU - Kavanaugh, Arthur

AU - Luqmani, Raashid

AU - Mosca, Marta

AU - Pincus, Theodore

AU - Porter, Duncan

AU - Rantalaiho, Vappu

AU - Ravelli, Angelo

AU - Scott, David L.

AU - Smolen, Josef

AU - Thielscher, Christian

AU - Turchetti, Giuseppe

AU - Van Den Broek, Marianne

AU - Yazici, Yusuf

PY - 2012/12/4

Y1 - 2012/12/4

UR - http://www.scopus.com/inward/record.url?scp=84870264019&partnerID=8YFLogxK

M3 - Editorial

AN - SCOPUS:84870264019

SN - 0392-856X

VL - 30

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 4 SUPPL.73

ER -

Treat-to-target in rheumatoid arthritis: Clinical and pharmacoeconomic considerations

Other files and links

Cite this